Correlation Between HbA1c and Body Mass Index Among Patients with High Lipid Profile Attending Johns Hopkins Aramco Healthcare Hospital in Saudi Arabia

Author:

Kheir Omer,Dossary Sheikha,Dhalaan Mohammad,AlHajri Salman,Aljeshi Ali,Wali Dawoud Raseel,Ghamdi Mohammad

Abstract

BACKGROUND AND OBJECTIVES: Dyslipidemia is a modifiable risk factor for cardiovascular diseases, diabetes, and stroke. The primary objective of this study was to examine the relationship between HbA1C and body mass index (BMI) among patients with high lipid profiles. METHODS: This retrospective, hospital-based study was conducted at Johns Hopkins Aramco Healthcare Facilities. Data were extracted from medical health records and included demographics, lipid profiles, and HBA1c measurements. The study included 2368 non-diabetic participants, and DATAtab was used to analyze the data. RESULTS: The participants were 57.05% male and 78.42% Saudi. The mean age was 41.48±12.1 years, and the mean body mass index (BMI) was 28.44±5.53. There was a statistically significant relationship between the use of lipid lowering medicine and HbA1c (P<0.001). There was a very weak positive but statistically significant relationship between HbA1c and BMI (r = 0.18, P<0.001). HbA1c and systolic blood pressure appeared to have a statistically significant positive association (r = 0.16, P< 0.001). There was no correlation between HbA1c and low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), or diastolic blood pressure. There was an inverse correlation between HbA1c and high-density lipoprotein cholesterol (HDL-C) (r = -0.11, P< 0.001). Regression was performed using a linear multivariable analysis with HbA1c as the dependent variable, and age (B 0.192, P<0.001), BMI (B 0.119, P<0.001), HDL (B -0.058, P<0.005), triglyceride (B 0.093, P<0.001), lipid-lowering medication (B 0.104, P<0.001), systolic BP (B 0.060, P< 0.003) as independent variables.  CONCLUSION: The results indicated that HbA1c is linked to BMI, age, systolic blood pressure, triglycerides, and HDL-C levels. There was no correlation between HbA1c and LDL-C, TC, and diastolic blood pressure.

Publisher

Qeios Ltd

Reference39 articles.

1. Satoh M, Ohkubo T, Asayama K, Murakami Y, Sakurai M, Nakagawa H, Iso H, Okayama A, Miura K, Imai Y, Ueshima H, Okamura T; Evidence for Cardiovascular Prevention From Observational Cohorts in Japan (EPOCH–JAPAN) Research Group*. Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan. Hypertension. 2015 Mar;65(3):517-24. doi: 10.1161/HYPERTENSIONAHA.114.04639. Epub 2015 Jan 19. PMID: 25601929.

2. The Emerging Risk Factors Collaboration*. Lipid-Related Markers and Cardiovascular Disease Prediction. JAMA. 2012;307(23):2499–2506. doi:10.1001/jama.2012.6571

3. Turgeon RD, Anderson TJ, Grégoire J, Pearson GJ. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2017;150(4):243-250. doi:10.1177/1715163517713031

4. Katulanda P, Dissanayake HA, De Silva SDN, Katulanda GW, Liyanage IK, Constantine GR, Sheriff R, Matthews DR. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006. J Clin Lipidol. 2018 Mar-Apr;12(2):447-454. doi: 10.1016/j.jacl.2018.01.006. Epub 2018 Jan 31. PMID: 29429894.

5. Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study. Diabetes Care. 2017 Apr;40(4):529-537. doi: 10.2337/dc16-1958. Epub 2017 Jan 25. PMID: 28122840; PMCID: PMC5360283.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3